Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

By Reneerkens Olga   Rutten Kris   Steinbusch Harry   Blokland Arjan   Prickaerts Jos  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 419-443

Springer Publishing Company

Access to resources Recommend Favorite

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 317-331

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3813-3828

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase inhibitors in clinical urology

By Ückert Stefan   Kuczyk Markus A   Oelke Matthias  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 323-332

Informa Healthcare

Access to resources Recommend Favorite

The role of phosphodiesterase inhibitors in impotence

By Eardley I.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1803-1810

Informa Healthcare

Access to resources Recommend Favorite